Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Jul;76(1):1–6. doi: 10.1172/JCI111930

Vitamin D-endocrine system.

N H Bell
PMCID: PMC423692  PMID: 2991334

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe E., Miyaura C., Sakagami H., Takeda M., Konno K., Yamazaki T., Yoshiki S., Suda T. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990–4994. doi: 10.1073/pnas.78.8.4990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams J. S., Sharma O. P., Gacad M. A., Singer F. R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983 Nov;72(5):1856–1860. doi: 10.1172/JCI111147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adams J. S., Singer F. R., Gacad M. A., Sharma O. P., Hayes M. J., Vouros P., Holick M. F. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab. 1985 May;60(5):960–966. doi: 10.1210/jcem-60-5-960. [DOI] [PubMed] [Google Scholar]
  4. Amento E. P., Bhalla A. K., Kurnick J. T., Kradin R. L., Clemens T. L., Holick S. A., Holick M. F., Krane S. M. 1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest. 1984 Mar;73(3):731–739. doi: 10.1172/JCI111266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bar-Shavit Z., Kahn A. J., Teitelbaum S. L. Defective binding of macrophages to bone in rodent osteomalacia and vitamin D deficiency. In vitro evidence for a cellular defect and altered saccharides in the bone matrix. J Clin Invest. 1983 Aug;72(2):526–534. doi: 10.1172/JCI111000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bar-Shavit Z., Noff D., Edelstein S., Meyer M., Shibolet S., Goldman R. 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcif Tissue Int. 1981;33(6):673–676. doi: 10.1007/BF02409507. [DOI] [PubMed] [Google Scholar]
  7. Bar-Shavit Z., Teitelbaum S. L., Kahn A. J. Saccharides mediate the attachment of rat macrophages to bone in vitro. J Clin Invest. 1983 Aug;72(2):516–525. doi: 10.1172/JCI110999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bar-Shavit Z., Teitelbaum S. L., Reitsma P., Hall A., Pegg L. E., Trial J., Kahn A. J. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5907–5911. doi: 10.1073/pnas.80.19.5907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Baran D. T., Milne M. L. 1,25 dihydroxyvitamin D-induced inhibition of 3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro. Calcif Tissue Int. 1983 Jul;35(4-5):461–464. doi: 10.1007/BF02405077. [DOI] [PubMed] [Google Scholar]
  10. Barbour G. L., Coburn J. W., Slatopolsky E., Norman A. W., Horst R. L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med. 1981 Aug 20;305(8):440–443. doi: 10.1056/NEJM198108203050807. [DOI] [PubMed] [Google Scholar]
  11. Bell N. H., Epstein S., Greene A., Shary J., Oexmann M. J., Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest. 1985 Jul;76(1):370–373. doi: 10.1172/JCI111971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bell N. H., Shaw S., Turner R. T. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984 Oct;74(4):1540–1544. doi: 10.1172/JCI111568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bell N. H., Stern P. H., Pantzer E., Sinha T. K., DeLuca H. F. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest. 1979 Jul;64(1):218–225. doi: 10.1172/JCI109442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Beresford J. N., Gallagher J. A., Poser J. W., Russell R. G. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res. 1984;5(5):229–234. doi: 10.1016/0221-8747(84)90064-x. [DOI] [PubMed] [Google Scholar]
  15. Bhalla A. K., Amento E. P., Clemens T. L., Holick M. F., Krane S. M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983 Dec;57(6):1308–1310. doi: 10.1210/jcem-57-6-1308. [DOI] [PubMed] [Google Scholar]
  16. Bhalla A. K., Amento E. P., Serog B., Glimcher L. H. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol. 1984 Oct;133(4):1748–1754. [PubMed] [Google Scholar]
  17. Bhattacharyya M. H., DeLuca H. F. The regulation of calciferol-25-hydroxylase in the chick. Biochem Biophys Res Commun. 1974 Jul 24;59(2):734–741. doi: 10.1016/s0006-291x(74)80041-0. [DOI] [PubMed] [Google Scholar]
  18. Booth B. E., Tsai H. C., Morris R. C., Jr Vitamin D status regulates 25-hydroxyvitamin D3-1 alpha-hydroxylase and its responsiveness to parathyroid hormone in the chick. J Clin Invest. 1985 Jan;75(1):155–161. doi: 10.1172/JCI111668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Breslau N. A., McGuire J. L., Zerwekh J. E., Frenkel E. P., Pak C. Y. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med. 1984 Jan;100(1):1–6. doi: 10.7326/0003-4819-100-1-1. [DOI] [PubMed] [Google Scholar]
  20. Breslau N. A., McGuire J. L., Zerwekh J. E., Pak C. Y. The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab. 1982 Aug;55(2):369–373. doi: 10.1210/jcem-55-2-369. [DOI] [PubMed] [Google Scholar]
  21. Broadus A. E., Insogna K. L., Lang R., Ellison A. F., Dreyer B. E. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med. 1984 Jul 12;311(2):73–80. doi: 10.1056/NEJM198407123110201. [DOI] [PubMed] [Google Scholar]
  22. Brooks M. H., Bell N. H., Love L., Stern P. H., Orfei E., Queener S. F., Hamstra A. J., DeLuca H. F. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med. 1978 May 4;298(18):996–999. doi: 10.1056/NEJM197805042981804. [DOI] [PubMed] [Google Scholar]
  23. Burger E. H., Van der Meer J. W., van de Gevel J. S., Gribnau J. C., Thesingh G. W., van Furth R. In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med. 1982 Dec 1;156(6):1604–1614. doi: 10.1084/jem.156.6.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Chen T. L., Hirst M. A., Feldman D. A receptor-like binding macromolecule for 1 alpha, 25-dihydroxycholecalciferol in cultured mouse bone cells. J Biol Chem. 1979 Aug 25;254(16):7491–7494. [PubMed] [Google Scholar]
  25. Cohn S. H., Abesamis C., Yasumura S., Aloia J. F., Zanzi I., Ellis K. J. Comparative skeletal mass and radial bone mineral content in black and white women. Metabolism. 1977 Feb;26(2):171–178. doi: 10.1016/0026-0495(77)90052-x. [DOI] [PubMed] [Google Scholar]
  26. Delvin E. E., Glorieux F. H. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets. Calcif Tissue Int. 1981;33(2):173–175. doi: 10.1007/BF02409431. [DOI] [PubMed] [Google Scholar]
  27. Epstein S., Stern P. H., Bell N. H., Dowdeswell I., Turner R. T. Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif Tissue Int. 1984 Sep;36(5):541–544. doi: 10.1007/BF02405362. [DOI] [PubMed] [Google Scholar]
  28. Esvelt R. P., Schnoes H. K., DeLuca H. F. Isolation and characterization of 1 alpha-hydroxy-23-carboxytetranorvitamin D: a major metabolite of 1,25-dihydroxyvitamin D3. Biochemistry. 1979 Sep 4;18(18):3977–3983. doi: 10.1021/bi00585a021. [DOI] [PubMed] [Google Scholar]
  29. FISCHMAN D. A., HAY E. D. Origin of osteoclasts from mononuclear leucocytes in regenerating newt limbs. Anat Rec. 1962 Aug;143:329–337. doi: 10.1002/ar.1091430402. [DOI] [PubMed] [Google Scholar]
  30. Feldman D., Chen T., Cone C., Hirst M., Shani S., Benderli A., Hochberg Z. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. J Clin Endocrinol Metab. 1982 Nov;55(5):1020–1022. doi: 10.1210/jcem-55-5-1020. [DOI] [PubMed] [Google Scholar]
  31. Fraser D. R., Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970 Nov 21;228(5273):764–766. doi: 10.1038/228764a0. [DOI] [PubMed] [Google Scholar]
  32. Gallagher J. C., Riggs B. L., Eisman J., Hamstra A., Arnaud S. B., DeLuca H. F. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest. 1979 Sep;64(3):729–736. doi: 10.1172/JCI109516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Garabedian M., Holick M. F., Deluca H. F., Boyle I. T. Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1673–1676. doi: 10.1073/pnas.69.7.1673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gkonos P. J., London R., Hendler E. D. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med. 1984 Dec 27;311(26):1683–1685. doi: 10.1056/NEJM198412273112607. [DOI] [PubMed] [Google Scholar]
  35. Griffin J. E., Zerwekh J. E. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3. J Clin Invest. 1983 Oct;72(4):1190–1199. doi: 10.1172/JCI111074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Harnden D., Kumar R., Holick M. F., Deluca H. F. Side chain metabolism of 25-hydroxy-[26,27-14C] vitamin D3 and 1,25-dihydroxy-[26,27-14C] vitamin D3 in vivo. Science. 1976 Aug 6;193(4252):493–494. doi: 10.1126/science.941020. [DOI] [PubMed] [Google Scholar]
  37. Heaney R. P., Recker R. R., Saville P. D. Menopausal changes in calcium balance performance. J Lab Clin Med. 1978 Dec;92(6):953–963. [PubMed] [Google Scholar]
  38. Henry H. L. Insulin permits parathyroid hormone stimulation of 1,25-dihydroxyvitamin D3 production in cultured kidney cells. Endocrinology. 1981 Feb;108(2):733–735. doi: 10.1210/endo-108-2-733. [DOI] [PubMed] [Google Scholar]
  39. Henry H. L., Midgett R. J., Norman A. W. Regulation of 25-hydroxyvitamin D3-1-hydroxylase in vivo. J Biol Chem. 1974 Dec 10;249(23):7584–7592. [PubMed] [Google Scholar]
  40. Henry H. L. Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells. J Biol Chem. 1979 Apr 25;254(8):2722–2729. [PubMed] [Google Scholar]
  41. Holick M. F., Kleiner-Bossaller A., Schnoes H. K., Kasten P. M., Boyle I. T., DeLuca H. F. 1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. J Biol Chem. 1973 Oct 10;248(19):6691–6696. [PubMed] [Google Scholar]
  42. Holick M. F., MacLaughlin J. A., Clark M. B., Holick S. A., Potts J. T., Jr, Anderson R. R., Blank I. H., Parrish J. A., Elias P. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science. 1980 Oct 10;210(4466):203–205. doi: 10.1126/science.6251551. [DOI] [PubMed] [Google Scholar]
  43. Holtrop M. E., Cox K. A., Clark M. B., Holick M. F., Anast C. S. 1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology. 1981 Jun;108(6):2293–2301. doi: 10.1210/endo-108-6-2293. [DOI] [PubMed] [Google Scholar]
  44. Honma Y., Hozumi M., Abe E., Konno K., Fukushima M., Hata S., Nishii Y., DeLuca H. F., Suda T. 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci U S A. 1983 Jan;80(1):201–204. doi: 10.1073/pnas.80.1.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Howard G. A., Turner R. T., Sherrard D. J., Baylink D. J. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem. 1981 Aug 10;256(15):7738–7740. [PubMed] [Google Scholar]
  46. Hughes M. R., Baylink D. J., Gonnerman W. A., Toverud S. U., Ramp W. K., Haussler M. R. Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat. Endocrinology. 1977 Mar;100(3):799–806. doi: 10.1210/endo-100-3-799. [DOI] [PubMed] [Google Scholar]
  47. Hughes M. R., Baylink D. J., Jones P. G., Haussler M. R. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest. 1976 Jul;58(1):61–70. doi: 10.1172/JCI108459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Kahn A. J., Simmons D. J. Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue. Nature. 1975 Nov 27;258(5533):325–327. doi: 10.1038/258325a0. [DOI] [PubMed] [Google Scholar]
  49. Kahn A. J., Stewart C. C., Teitelbaum S. L. Contact-mediated bone resorption by human monocytes in vitro. Science. 1978 Mar 3;199(4332):988–990. doi: 10.1126/science.622581. [DOI] [PubMed] [Google Scholar]
  50. Kantarjian H. M., Saad M. F., Estey E. H., Sellin R. V., Samaan N. A. Hypercalcemia in disseminated candidiasis. Am J Med. 1983 Apr;74(4):721–724. doi: 10.1016/0002-9343(83)91033-1. [DOI] [PubMed] [Google Scholar]
  51. Key L., Carnes D., Cole S., Holtrop M., Bar-Shavit Z., Shapiro F., Arceci R., Steinberg J., Gundberg C., Kahn A. Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med. 1984 Feb 16;310(7):409–415. doi: 10.1056/NEJM198402163100701. [DOI] [PubMed] [Google Scholar]
  52. Knox F. G., Schneider E. G., Willis L. R., Strandhoy J. W., Ott C. E., Cuche J. L., Goldsmith R. S., Arnaud C. D. Proximal tubule reabsorption after hyperoncotic albumin infusion. Role of parathyroid hormone and dissociation from plasma volume. J Clin Invest. 1974 Feb;53(2):501–507. doi: 10.1172/JCI107583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Knutson J. C., DeLuca H. F. 25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties. Biochemistry. 1974 Mar 26;13(7):1543–1548. doi: 10.1021/bi00704a034. [DOI] [PubMed] [Google Scholar]
  54. Ko J. S., Bernard G. W. Osteoclast formation in vitro from bone marrow mononuclear cells in osteoclast-free bone. Am J Anat. 1981 Aug;161(4):415–425. doi: 10.1002/aja.1001610407. [DOI] [PubMed] [Google Scholar]
  55. Koeffler H. P., Amatruda T., Ikekawa N., Kobayashi Y., DeLuca H. F. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res. 1984 Dec;44(12 Pt 1):5624–5628. [PubMed] [Google Scholar]
  56. Kozeny G. A., Barbato A. L., Bansal V. K., Vertuno L. L., Hano J. E. Hypercalcemia associated with silicone-induced granulomas. N Engl J Med. 1984 Oct 25;311(17):1103–1105. doi: 10.1056/NEJM198410253111707. [DOI] [PubMed] [Google Scholar]
  57. Kream B. E., Jose M., Yamada S., DeLuca H. F. A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone. Science. 1977 Sep 9;197(4308):1086–1088. doi: 10.1126/science.887939. [DOI] [PubMed] [Google Scholar]
  58. Kumar R., Nagubandi S., Mattox V. R., Londowski J. M. Enterohepatic physiology of 1,25-dihydroxyvitamin D3. J Clin Invest. 1980 Feb;65(2):277–284. doi: 10.1172/JCI109669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Kuribayashi T., Tanaka H., Abe E., Suda T. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3. Endocrinology. 1983 Dec;113(6):1992–1998. doi: 10.1210/endo-113-6-1992. [DOI] [PubMed] [Google Scholar]
  60. Lambert P. W., Hollis B. W., Bell N. H., Epstein S. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism. J Clin Invest. 1980 Oct;66(4):782–791. doi: 10.1172/JCI109916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Lambert P. W., Stern P. H., Avioli R. C., Brackett N. C., Turner R. T., Greene A., Fu I. Y., Bell N. H. Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man. J Clin Invest. 1982 Mar;69(3):722–725. doi: 10.1172/JCI110501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Leong A. S., Disney A. P., Gove D. W. Spallation and migration of silicone from blood-pump tubing in patients on hemodialysis. N Engl J Med. 1982 Jan 21;306(3):135–140. doi: 10.1056/NEJM198201213060303. [DOI] [PubMed] [Google Scholar]
  63. Liberman U. A., Eil C., Marx S. J. Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts. J Clin Invest. 1983 Feb;71(2):192–200. doi: 10.1172/JCI110759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Lorente F., Fontan G., Jara P., Casas C., Garcia-Rodriguez M. C., Ojeda J. A. Defective neutrophil motility in hypovitaminosis D rickets. Acta Paediatr Scand. 1976 Nov;65(6):695–699. doi: 10.1111/j.1651-2227.1976.tb18005.x. [DOI] [PubMed] [Google Scholar]
  65. Lund B., Sørensen O. H., Lund B., Bishop J. E., Norman A. W. Vitamin D metabolism in hypoparathyroidism. J Clin Endocrinol Metab. 1980 Sep;51(3):606–610. doi: 10.1210/jcem-51-3-606. [DOI] [PubMed] [Google Scholar]
  66. Lyles K. W., Clark A. G., Drezner M. K. Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia. Calcif Tissue Int. 1982 Mar;34(2):125–130. doi: 10.1007/BF02411222. [DOI] [PubMed] [Google Scholar]
  67. Lyles K. W., Drezner M. K. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity. J Clin Endocrinol Metab. 1982 Mar;54(3):638–644. doi: 10.1210/jcem-54-3-638. [DOI] [PubMed] [Google Scholar]
  68. Malone J. D., Teitelbaum S. L., Griffin G. L., Senior R. M., Kahn A. J. Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol. 1982 Jan;92(1):227–230. doi: 10.1083/jcb.92.1.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Mangelsdorf D. J., Koeffler H. P., Donaldson C. A., Pike J. W., Haussler M. R. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984 Feb;98(2):391–398. doi: 10.1083/jcb.98.2.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Manolagas S. C., Burton D. W., Deftos L. J. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem. 1981 Jul 25;256(14):7115–7117. [PubMed] [Google Scholar]
  71. Marx S. J., Spiegel A. M., Brown E. M., Gardner D. G., Downs R. W., Jr, Attie M., Hamstra A. J., DeLuca H. F. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 1978 Dec;47(6):1303–1310. doi: 10.1210/jcem-47-6-1303. [DOI] [PubMed] [Google Scholar]
  72. Mason R. S., Frankel T., Chan Y. L., Lissner D., Posen S. Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med. 1984 Jan;100(1):59–61. doi: 10.7326/0003-4819-100-1-59. [DOI] [PubMed] [Google Scholar]
  73. Mayfield R. K., Bell N. K. No evidence for regulation of plasma renin by 1,25-dihydroxyvitamin D3. N Engl J Med. 1985 May 2;312(18):1195–1196. doi: 10.1056/NEJM198505023121821. [DOI] [PubMed] [Google Scholar]
  74. McCarthy D. M., San Miguel J. F., Freake H. C., Green P. M., Zola H., Catovsky D., Goldman J. M. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res. 1983;7(1):51–55. doi: 10.1016/0145-2126(83)90057-7. [DOI] [PubMed] [Google Scholar]
  75. Norman A. W., Roth J., Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev. 1982 Fall;3(4):331–366. doi: 10.1210/edrv-3-4-331. [DOI] [PubMed] [Google Scholar]
  76. Norman D. A., Fordtran J. S., Brinkley L. J., Zerwekh J. E., Nicar M. J., Strowig S. M., Pak C. Y. Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest. 1981 Jun;67(6):1599–1603. doi: 10.1172/JCI110194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Papapoulos S. E., Clemens T. L., Fraher L. J., Lewin I. G., Sandler L. M., O'Riordan J. L. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet. 1979 Mar 24;1(8117):627–630. doi: 10.1016/s0140-6736(79)91076-6. [DOI] [PubMed] [Google Scholar]
  78. Pike J. W., Dokoh S., Haussler M. R., Liberman U. A., Marx S. J., Eil C. Vitamin D3--resistant fibroblasts have immunoassayable 1,25-dihydroxyvitamin D3 receptors. Science. 1984 May 25;224(4651):879–881. doi: 10.1126/science.6326262. [DOI] [PubMed] [Google Scholar]
  79. Pike J. W., Haussler M. R. Purification of chicken intestinal receptor for 1,25-dihydroxyvitamin D. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5485–5489. doi: 10.1073/pnas.76.11.5485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Pike J. W., Marion S. L., Donaldson C. A., Haussler M. R. Serum and monoclonal antibodies against the chick intestinal receptor for 1,25-dihydroxyvitamin D3. Generation by a preparation enriched in a 64,000-dalton protein. J Biol Chem. 1983 Jan 25;258(2):1289–1296. [PubMed] [Google Scholar]
  81. Ponchon G., DeLuca H. F. The role of the liver in the metabolism of vitamin D. J Clin Invest. 1969 Jul;48(7):1273–1279. doi: 10.1172/JCI106093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Price P. A., Baukol S. A. 1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem. 1980 Dec 25;255(24):11660–11663. [PubMed] [Google Scholar]
  83. Price P. A., Baukol S. A. 1,25-dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein. Biochem Biophys Res Commun. 1981 Apr 15;99(3):928–935. doi: 10.1016/0006-291x(81)91252-3. [DOI] [PubMed] [Google Scholar]
  84. Prince M. J., Schaeffer P. C., Goldsmith R. S., Chausmer A. B. Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations. Ann Intern Med. 1982 May;96(5):586–591. doi: 10.7326/0003-4819-96-5-586. [DOI] [PubMed] [Google Scholar]
  85. Provvedini D. M., Tsoukas C. D., Deftos L. J., Manolagas S. C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983 Sep 16;221(4616):1181–1183. doi: 10.1126/science.6310748. [DOI] [PubMed] [Google Scholar]
  86. Raisz L. G., Trummel C. L., Holick M. F., DeLuca H. F. 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science. 1972 Feb 18;175(4023):768–769. doi: 10.1126/science.175.4023.768. [DOI] [PubMed] [Google Scholar]
  87. Rasmussen H., Wong M., Bikle D., Goodman D. B. Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest. 1972 Sep;51(9):2502–2504. doi: 10.1172/JCI107065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Reitsma P. H., Rothberg P. G., Astrin S. M., Trial J., Bar-Shavit Z., Hall A., Teitelbaum S. L., Kahn A. J. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature. 1983 Dec 1;306(5942):492–494. doi: 10.1038/306492a0. [DOI] [PubMed] [Google Scholar]
  89. Rickers H., Christiansen C., Balslev I., Rødbro P. Impairment of vitamin D metabolism and bone mineral content after intestinal bypass for obesity. A longitudinal study. Scand J Gastroenterol. 1984 Mar;19(2):184–189. [PubMed] [Google Scholar]
  90. Rosenthal N., Insogna K. L., Godsall J. W., Smaldone L., Waldron J. A., Stewart A. F. Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab. 1985 Jan;60(1):29–33. doi: 10.1210/jcem-60-1-29. [DOI] [PubMed] [Google Scholar]
  91. SCHACHTER D., FINKELSTEIN J. D., KOWARSKI S. METABOLISM OF VITAMIN D. I. PREPARATION OF RADIOACTIVE VITAMIN D AND ITS INTESTINAL ABSORPTION IN THE RAT. J Clin Invest. 1964 May;43:787–796. doi: 10.1172/JCI104965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Shinki T., Shiina Y., Takahashi N., Tanioka Y., Koizumi H., Suda T. Extremely high circulating levels of 1 alpha,25-dihydroxyvitamin D3 in the marmoset, a new world monkey. Biochem Biophys Res Commun. 1983 Jul 29;114(2):452–457. doi: 10.1016/0006-291x(83)90801-x. [DOI] [PubMed] [Google Scholar]
  93. Shinki T., Takahashi N., Kadofuku T., Sato T., Suda T. Induction of spermidine N1-acetyltransferase by 1 alpha,25-dihydroxyvitamin D3 as an early common event in the target tissues of vitamin D. J Biol Chem. 1985 Feb 25;260(4):2185–2190. [PubMed] [Google Scholar]
  94. Shinki T., Takahashi N., Miyaura C., Samejima K., Nishii Y., Suda T. Ornithine decarboxylase activity in chick duodenum induced by 1 alpha, 25-dihydroxycholecalciferol. Biochem J. 1981 Jun 1;195(3):685–690. doi: 10.1042/bj1950685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Simpson R. U., DeLuca H. F. Purification of chicken intestinal receptor for 1 alpha, 25-dihydroxyvitamin D3 to apparent homogeneity. Proc Natl Acad Sci U S A. 1982 Jan;79(1):16–20. doi: 10.1073/pnas.79.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Spencer R., Charman M., Lawson D. E., Emtage J. S. Production and properties of vitamin-D-induced mRNA for chick calcium-binding protein. Eur J Biochem. 1976 Dec 11;71(2):399–409. doi: 10.1111/j.1432-1033.1976.tb11127.x. [DOI] [PubMed] [Google Scholar]
  97. Spencer R., Charman M., Lawson D. E. Stimulation of intestinal calcium-binding-protein mRNA synthesis in the nucleus of vitamin D-deficient chicks by 1,25-dihydroxycholecalciferol. Biochem J. 1978 Dec 1;175(3):1089–1094. doi: 10.1042/bj1751089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Stern P. H., De Olazabal J., Bell N. H. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest. 1980 Oct;66(4):852–855. doi: 10.1172/JCI109924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Stern P. H., Taylor A. B., Bell N. H., Epstein S. Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. J Clin Invest. 1981 Nov;68(5):1374–1377. doi: 10.1172/JCI110386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Ströder J., Kasal P. Evaluation of phagocytosis in rickets. Acta Paediatr Scand. 1970 May;59(3):288–292. doi: 10.1111/j.1651-2227.1970.tb09005.x. [DOI] [PubMed] [Google Scholar]
  101. TROTTER M., BROMAN G. E., PETERSON R. R. Densites of bones of white and Negro skeletons. J Bone Joint Surg Am. 1960 Jan;42-A:50–58. [PubMed] [Google Scholar]
  102. Tahaka Y., Lorenc R. S., DeLuca H. F. The role of 1,25-dihydroxyvitamin D3 and parathyroid hormone in the regulation of chick renal 25-hydroxyvitamin D3-24-hydroxylase. Arch Biochem Biophys. 1975 Dec;171(2):521–526. doi: 10.1016/0003-9861(75)90061-2. [DOI] [PubMed] [Google Scholar]
  103. Tanaka H., Abe E., Miyaura C., Kuribayashi T., Konno K., Nishii Y., Suda T. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982 Jun 15;204(3):713–719. doi: 10.1042/bj2040713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Tanaka H., Abe E., Miyaura C., Shiina Y., Suda T. 1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun. 1983 Nov 30;117(1):86–92. doi: 10.1016/0006-291x(83)91544-9. [DOI] [PubMed] [Google Scholar]
  105. Tanaka Y., DeLuca H. F. Stimulation of 24,25-dihydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3. Science. 1974 Mar;183(130):1198–1200. doi: 10.1126/science.183.4130.1198. [DOI] [PubMed] [Google Scholar]
  106. Tanaka Y., Halloran B., Schnoes H. K., DeLuca H. F. In vitro production of 1,25-dihydroxyvitamin D3 by rat placental tissue. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5033–5035. doi: 10.1073/pnas.76.10.5033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Tsoukas C. D., Provvedini D. M., Manolagas S. C. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984 Jun 29;224(4656):1438–1440. doi: 10.1126/science.6427926. [DOI] [PubMed] [Google Scholar]
  108. Turner R. T., Howard G. A., Puzas J. E., Baylink D. J., Knapp D. R. Calvarial cells synthesize 1 alpha,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Biochemistry. 1983 Mar 1;22(5):1073–1076. doi: 10.1021/bi00274a012. [DOI] [PubMed] [Google Scholar]
  109. Turner R. T., Puzas J. E., Forte M. D., Lester G. E., Gray T. K., Howard G. A., Baylink D. J. In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5720–5724. doi: 10.1073/pnas.77.10.5720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. WIDROW S. H., LEVINSKY N. G. The effect of parathyroid extract on renal tubular calcium reabsorption in the dog. J Clin Invest. 1962 Dec;41:2151–2159. doi: 10.1172/JCI104673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Weisman Y., Harell A., Edelstein S., David M., Spirer Z., Golander A. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature. 1979 Sep 27;281(5729):317–319. doi: 10.1038/281317a0. [DOI] [PubMed] [Google Scholar]
  112. Whyte M. P., Haddad J. G., Jr, Walters D. D., Stamp T. C. Vitamin D bioavailability: serum 25-hydroxyvitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration. J Clin Endocrinol Metab. 1979 Jun;48(6):906–911. doi: 10.1210/jcem-48-6-906. [DOI] [PubMed] [Google Scholar]
  113. Wiesner R. H., Kumar R., Seeman E., Go V. L. Enterohepatic physiology of 1,25-dihydroxyvitamin D3 metabolites in normal man. J Lab Clin Med. 1980 Dec;96(6):1094–1100. [PubMed] [Google Scholar]
  114. Yamaoka K., Seino Y., Ishida M., Ishii T., Shimotsuji T., Tanaka Y., Kurose H., Matsuda S., Satomura K., Yabuuchi H. Effect of dibutyryl adenosine 3',5'-monophosphate administration on plasma concentrations of 1,25-dihydroxyvitamin D in pseudohypoparathyroidism type I. J Clin Endocrinol Metab. 1981 Nov;53(5):1096–1100. doi: 10.1210/jcem-53-5-1096. [DOI] [PubMed] [Google Scholar]
  115. Yetgin S., Ozsoylu S. Myeloid metaplasia in vitamin D deficiency rickets. Scand J Haematol. 1982 Feb;28(2):180–185. doi: 10.1111/j.1600-0609.1982.tb00512.x. [DOI] [PubMed] [Google Scholar]
  116. Zerwekh J. E., Glass K., Jowsey J., Pak C. Y. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 1979 Aug;49(2):171–175. doi: 10.1210/jcem-49-2-171. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES